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ABSTRACT
Background: Bacterial vaginosis (BV) is one of the most common vaginal infections
worldwide. It is associated with the presence of a dense polymicrobial biofilm on the
vaginal epithelium, formed mainly by Gardnerella species. The biofilm also contains
other anaerobic species, but little is known about their role in BV development.
Aim: To evaluate the influence of different culture media on the planktonic and
biofilm growth of six cultivable anaerobes frequently associated with BV, namely
Gardnerella sp., Atopobium vaginae, Lactobacillus iners, Mobiluncus curtisii,
Peptostreptococcus anaerobius and Prevotella bivia.
Methods: A total of nine different culture media compositions, including
commercially available and chemically defined media simulating genital tract
secretions, were tested in this study. Planktonic cultures and biofilms were grown
under anaerobic conditions (10% carbon dioxide, 10% helium and 80% nitrogen).
Planktonic growth was assessed by optical density measurements, and biofilm
formation was quantified by crystal violet staining.
Results: Significant planktonic growth was observed for Gardnerella sp., A. vaginae
and L. iners in New York City III broth, with or without ascorbic acid
supplementation. Biofilm quantification showed high in vitro biofilm growth for
Gardnerella sp., P. anaerobius and P. bivia in almost all culture media excluding
Brucella broth. Contrary, only New York City III broth was able to promote biofilm
formation for A. vaginae, L. iners and M. curtisii.
Conclusions: Our data demonstrate that New York City III broth relative to the
other tested media is the most conducive for future studies addressing polymicrobial
biofilms development as this culture medium allowed the formation of significant
levels of single-species biofilms.
Subjects Microbiology, Gynecology and Obstetrics, Women’s Health
Keywords Bacterial vaginosis, BV-associated anaerobes, Anaerobic growth, Biofilms
INTRODUCTION
Bacterial vaginosis (BV) is the worldwide leading bacterial vaginal infection commonly
recognized in women of all ethnicities between menarche and menopause (Beamer et al.,
2017; Javed, Parvaiz & Manzoor, 2019). BV is often characterized by a decrease of
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beneficial vaginal bacteria, mainly hydrogen peroxide and lactic acid-producing
Lactobacillus species, and by an increase of anaerobic pathogens (Marrazzo, 2011;
Schwebke, 2000). The most prominent of these is Gardnerella vaginalis, a facultative
anaerobe usually found embedded in a polymicrobial biofilm (Swidsinski et al., 2014).
It is important to mention that an emended description of G. vaginalis was recently
proposed with the delineation of 13 genomic species within the genus Gardnerella
(Vaneechoutte et al., 2019). Of these 13 species, three were officially described (G. leopoldii,
G. piotii, and G. swidsinskii) and G. vaginalis was amended. Following this renewed
taxonomy of the genus Gardnerella, in this article, the term Gardnerella spp. will be used to
address previous publications, since we cannot rule out the fact that other Gardnerella
species were involved.
According to the current hypothesis for BV pathogenesis, Gardnerella spp. initiate the
formation of the biofilm on vaginal epithelial cells and become a scaffolding to which
other BV-associated species thereafter can attach (Muzny et al., 2019). One of the species
that is often found associated with Gardnerella spp. biofilms is Atopobium vaginae
(Swidsinski et al., 2005). Under specific in vitro conditions, G. vaginalis enhances
culturability of A. vaginae (Castro et al., 2020) and it has been suggested that the in vivo
detection of both bacteria is a strong indicator of BV development (Bradshaw et al., 2006;
Hardy et al., 2016, 2015; Muzny et al., 2019). However, the BV biofilm is often populated
by many other facultative or strict anaerobes, but very little is known about their role in BV
development. As such, more studies are needed to address the interactions between these
species. One issue facing researchers that work with BV-associated species is that most
species are uncultivable or fastidious (Diop et al., 2019; Fredricks et al., 2007; Fredricks,
Fiedler & Marrazzo, 2005; Srinivasan et al., 2016). Furthermore, in vitro biofilm formation
requirements are often different from planktonic growth (Alves et al., 2014). Considering
the increased focus on biofilm-associated infections and the demand for finding novel
treatment approaches (Falconi-McCahill, 2019), the current study was undertaken aiming
to evaluate the effects of nine different culture media on the planktonic growth and biofilm
formation of cultivable anaerobes frequently found in BV, namely Gardnerella sp.,
A. vaginae, Mobiluncus curtisii, Peptostreptococcus anaerobius and Prevotella bivia (Diop
et al., 2019; Onderdonk, Delaney & Fichorova, 2016). Importantly, Lactobacillus iners
was also included in this study as this species plays a controversial role in the vaginal
microenvironment, being detected in the vaginal microbiota of both healthy (Anukam et al.,
2006; Ravel et al., 2011) and women with BV (Rampersaud et al., 2011). Furthermore, L. iners
has been often identified in the intermediate vaginal microbiota (i.e., between normal
and BV microbiota) (Jakobsson & Forsum, 2007; Petrova et al., 2015) and also dominates
the microbiota after treatment of BV (Ferris et al., 2007). Also, this microorganism
has complex nutritional requirements, being thus, not easy to work with in vitro
(Vaneechoutte, 2017).
As such, the main goal of this study was to explore growth conditions optimal for using
in future in vitro multi-species biofilm model, with the aim to better analyze BV
multi-species interactions and their impact on BV development.
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MATERIALS AND METHODS
Bacterial species and growth conditions
Six cultivable bacterial species associated with BV were used in the current study, namely
Gardnerella sp., A. vaginae, L. iners, M. curtisii, P. anaerobius and P. bivia (Table 1).
These species were preserved frozen in Brain Heart Infusion broth (BHI) (Liofilchem,
Italy) with 23% (v/v) glycerol (Panreac, Spain) at −80 C. Each species was inoculated from
the −80 C bacterial stock on plates containing Columbia Blood Agar medium (CBA)
(Oxoid, Basingstoke, UK) supplemented with 5% (v/v) defibrinated horse blood (Oxoid,
Basingstoke, UK) and incubated at 37 C under anaerobic conditions [controlled
atmosphere composed of 10% carbon dioxide (CO2), 10% helium and 80% nitrogen
generated by a cylinder (Air Liquid, Algés, Portugal) coupled to an anaerobic incubator
(Plas-Labs, Lansing, MI, USA)] for 2–4 days. For planktonic and biofilm assays, Brain
heart infusion broth supplemented with yeast extract, starch and gelatin (sBHI), Brucella
broth supplemented with hemin and vitamin K1 solutions (BHV), New York City III broth
supplemented with 10% (v/v) inactivated horse serum (NYC), Schaedler broth (SB),
and a medium simulating genital tract secretions (mGTS) were used as culture media with
the mentioned composition, but also supplemented with 0.1% (w/v) L-ascorbic acid
(Sigma–Aldrich, Gillingham, UK), excepting mGTS which already contains L-ascorbic
acid. The addition of L-ascorbic acid to the culture media was designated with the
abbreviation “Aa”, added at the end of each medium’s name mentioned above (e.g., sBHI
supplemented with L-ascorbic acid became sBHI.Aa). The detailed information about
each tested medium is presented in Table 2. In order to prepare hemin solution, 0.5 g of
hemin was dissolved in 10 mL of 1 N NaOH and afterwards distilled water was added
to reach the volume of 100 mL. Further, vitamin K1 solution was prepared by adding
0.025 mL of vitamin K1 stock solution to 4.975 mL of 95% ethanol. The prepared
solutions of hemin and vitamin K1 were used with a concentration of 0.0005% (w/v) and
0.0001% (w/v), respectively. In mGTS, Part III of this medium is a vitamin mixture,
Table 1 Cultivable bacterial species used for planktonic and biofilm growth assays.
Species Strain Origin Association with BV1
Gardnerella sp. UM2412 Isolated from women diagnosed with BV Often described
Atopobium vaginae ATCC BAA-55T Isolated from vaginal microbiota of a healthy woman (Jovita et al., 1999) Often described
Lactobacillus iners CCUG 28746T Isolated from human urine (Falsen et al., 1999) Commonly described
Mobiluncus curtisii ATCC 35241T Isolated from women with BV (Spiegel & Roberts, 1984) Commonly described
Peptostreptococcus anaerobius ATCC 27337T Isolated from female genital tract (Ng et al., 1994) Commonly described
Prevotella bivia ATCC 29303T Isolated from endometrium (Holdeman & Johnson, 1977) Commonly described
Notes:
1 To determine how often the selected cultivable species have been reported in BV, a query in PubMed was performed by using a specific combination of keywords as
“bacterial vaginosis” and “name of each species” (e.g., “Gardnerella”and “bacterial vaginosis”). We designated as “often described” those species referred in more than 50
articles in the last 25 years, while “commonly described” had at least 10 articles in the same period. Of note, the selected bacterial species used herein have been pointed
out in several studies (Diop et al., 2019; Onderdonk, Delaney & Fichorova, 2016; Ravel et al., 2011) as potential microbial pathogens involved in BV development.
2 The partial 16S ribosomal RNA gene sequences of Gardnerella sp. is downloadable from NCBI. UM: University of Minho, Portugal. In addition, the strain was
phenotypically and genotypically characterized by Castro et al. (2020, 2015), Castro, Jefferson & Cerca (2018). It is of note thatGardnerella sp. UM241 did not match with
any of theGardnerella species described by Vaneechoutte and colleagues (Vaneechoutte et al., 2019) (i.e., G. vaginalis, G. piotii,G. leopoldii andG. swidsinskii), belonging
to a yet unidentified Gardnerella species (Castro et al., 2020).
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Sigma K3129, from Sigma–Aldrich (UK) with the stock solution of 100× that was used at
a concentration of 0.5% (v/v).
Planktonic growth assessment
For the evaluation of planktonic growth, the inoculums were prepared by transferring
fresh bacterial colonies from CBA plates to 8 mL of each culture medium described above.
The obtained bacterial suspensions were adjusted by optical density (OD) at 620 nm to
0.10 ± 0.05 (EZ Read 800 Plus; Biochrom, Cambridge, UK) and equally distributed in two
Table 2 Culture media used for the growth of BV-associated anaerobes.
Culture medium Composition Supplementation Abbreviation
Brain heart infusion broth (Liofilchem,
Italy)



















New York City III broth 1.5% (w/v) Bacto proteose peptone no. 3 (BD, France);
0.5% (w/v) Glucose (Fisher Scientific, UK);
0.24% (w/v) HEPES (VWR, USA);
0.5% (w/v) NaCl (VWR, USA);







Schaedler broth (Liofilchem, Italy) As described by the manufacturer – SB/SB.Aa1
Chemically defined medium
simulating genital tract secretions
(Stingley et al., 2014)
Part I: 0.35% NaCl; 0.15% KCl; 0.174% K2HPO4; 0.136% KH2PO4;
1.08% glucose; 0.05% cysteine HCl.
Part II: 0.1% glycogen; 0.03% mucin; 0.02% tween 20; 0.05% urea;
0.0005% hemin; 0.0001% vitamin K1; 0.2% bovine serum albumin;
0.03% MgSO4; 0.004% NaHCO3; 0.1% sodium acetate; 0.005%
MnCl2.
Part III: 0.0005% biotin; 5.0% myo-inositol; 0.05% niacinamide; 0.05%
pyridoxine HCI; 0.05% thiamin HCI; 0.05% D-calcium
pantothenate; 0.05% folic acid; 0.001% p-aminobenzoic acid; 0.05%
choline chloride; 0.01% riboflavin; 0.1% L-ascorbic acid; 0.0005%
vitamin A (retinol); 0.0005% vitamin D (cholecalciferol); 0.001%
vitamin B12.
Part IV (amino acids): 0.032% alanine; 0.008% arginine; 0.076%
aspartic acid; 0.036% glutamic acid; 0.04% glutamine; 0.02% glycine;
0.016% histidine; 0.012% isoleucine; 0.02% leucine; 0.02% lysine;
0.004% methionine; 0.004% phenylalanine; 0.028% proline; 0.012%
serine; 0.012% threonine; 0.004% tryptophan; 0.02% tyrosine;
0.068% valine.
Part V (UPI): 0.05% uracil; 0.01% sodium pyruvate; 0.02% inosine.
– mGTS2
Notes:
1 The supplementation of the culture media with 0.1% (w/v) L-ascorbic acid was designated with the abbreviation “Aa”, added at the end of each medium’s name as
follows, for example, sBHI supplemented with L-ascorbic acid became sBHI.Aa. The other three culture media were abbreviated by following the same rule.
2 The mGTS medium has already 0.1% (w/v) L-ascorbic acid in its composition.
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sterile 15 mL falcon tubes (Orange Scientific, Braine-l’Alleud, Belgium) which were
further incubated at 37 C under anaerobic conditions for 48 h, as described above.
Afterwards, planktonic growth was assessed by OD620nm. Growth was normalized as a fold
difference between the final OD620nm and the starting OD (at time 0 h). The assays
were repeated at least three times on separate days, with four technical replicates
considered each time.
Biofilm formation and biomass quantification
Single-species biofilms of each tested species were initiated by inoculating bacterial
suspensions of 48 h cultures adjusted to an OD620nm of 0.10 ± 0.05 in sterile 96-well tissue
culture plates (Orange Scientific, Braine-l’Alleud, Belgium) and incubated for 72 h, at
37 C under anaerobic conditions. To quantify the biofilm biomass, we used the crystal
violet (CV) method, which is the most frequently employed approach for this purpose
(Azeredo et al., 2017; Peeters, Nelis & Coenye, 2008). In brief, following 72 h of incubation,
the biofilms were washed once with 0.9% (w/v) sodium chloride and allowed to air dry.
After, the biofilms were fixed with 100% (v/v) methanol (Thermo Fisher Scientific,
Waltham, MA, USA) for 20 min, and then stained with CV solution 1% (v/v) (Merck,
Darmstadt, Germany) for 20 min. Subsequently, each well was washed twice with 1% (v/v)
phosphate-buffered saline, and the bound CV was released with 33% (v/v) acetic acid
(Thermo Fisher Scientific, Lenexa, KS, USA). To assess the biomass, the OD of the
resulting solution was measured at 595 nm. Biofilm experiments were repeated at least
three times with eight technical replicates.
Statistical analysis
The data were analyzed using the statistical package GraphPad Prism version 6 (La Jolla,
CA, USA) by one-way ANOVA (Dunnett’s and Tukey’s multiple comparison tests)
and two-way ANOVA (Sidak’s multiple comparisons test). Values with a p < 0.05 and
p < 0.01 were considered statistically significant.
RESULTS
Planktonic growth assays
As shown in Fig. 1, BV-associated anaerobes had variable ability to grow planktonically in
the tested culture media. Accordingly, P. anaerobius and P. bivia had higher metabolic
flexibility and were able to grow in most of the tested media, while M. curtisii had more
restrictive growth requirements and presented low levels of growth in all of them.
Interestingly, NYC broth showed high levels of planktonic growth for the tested species,
being overpassed only by NYC.Aa for L. iners, SB and SB.Aa for P. anaerobius, and by
sBHI.Aa for P. bivia. The mGTS supported very low levels of bacterial growth, with only
Gardnerella sp., P. anaerobius and P. bivia showing moderate levels of growth.
Since it was previously shown that L-ascorbic acid could enhance the growth of several
anaerobic bacteria, including A. vaginae, Finegoldia magna, Fusobacterium necrophorum,
Prevotella nigrescens, Ruminococcus gnavus and Solobacterium moorei (La Scola et al.,
2014), we repeated the experiments with media supplemented with 0.1% (w/v) L-ascorbic
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acid. However, contrary to what was described before, the addition of 0.1% (w/v)
L-ascorbic acid had a very variable effect on bacterial growth, with only 33.3% (n = 8;
cut-off ≥ 1.25-fold change) of the total combinations tested yielding a significant increase
in bacterial growth, while in 4.17% (n = 1; cut-off < 0.75-fold change) an inhibition of
the growth was observed. In most of the tested combinations (n = 15; 0.75 ≤ fold
change < 1.25), no effect was observed (Table S1). The most notable case was observed
Figure 1 Fold change in planktonic growth of BV-associated bacteria in the nine different culture
media relative to OD620nm values measured at T0 h. (A) Experiments conducted with Gardnerella
sp. (B) Experiments conducted with A. vaginae. (C) Experiments conducted with L. iners. (D) Experi-
ments conducted with M. curtisii. (E) Experiments conducted with P. anaerobius. (F) Experiments
conducted with P. bivia. Results represent the average ± the standard deviation of at least three inde-
pendent experiments. Statistical analysis was performed using one-way ANOVA and Dunnett’s multiple
comparisons test. Significant differences between NYC medium (our culture medium of choice) and
other culture media are depicted with p < 0.05 and p < 0.01. Other statistical analysis is shown in
Table S1. Full-size DOI: 10.7717/peerj.9917/fig-1
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for P. bivia growth in SB, in which L-ascorbic acid increased almost seven-fold the
growth rate.
Biofilm assays
Not surprisingly, we observed that similar to planktonic growth, biofilm formation was
also strongly affected by the culture media composition, as depicted in Fig. 2. Importantly,
there was not a direct relationship between higher planktonic growth and higher
biofilm formation, which further confirms that the requirements for biofilm formation are
distinct than the requirements for planktonic growth, as showed before for many other
bacterial species (Alves et al., 2014; Heffernan, Murphy & Casey, 2009; Ripolles-Avila
et al., 2018; Wijesinghe et al., 2019). Further differences between biofilm formation and
planktonic growth were observed when adding L-ascorbic acid to the growth media, with
20.8% (n = 5) of the tested combinations species/growth medium resulting in a statistically
significant decrease in the biofilm-forming capacity (p < 0.05) and 37.5% (n = 9) of
the situations also presenting a visible biofilm reduction, however not statistically
significant as can be seen in Table S2. Moreover, the addition of L-ascorbic acid to the
culture media did not promote significantly increased biofilm formation in any of the
combinations tested (Fig. 2).
DISCUSSION
Despite the fact that BV is an increasingly important health problem, there is a lack of
studies addressing multi-species interactions that might occur during BV and their role
in the development of this infection. Most attempts to understand the microbiology
behind BV have been focused mainly on Gardnerella spp., perhaps because this species has
long been associated with BV development (Gardner & Dukes, 1955; Swidsinski et al.,
2005) and it has been now hypothesized that this microorganism is the initial colonizer of
the vaginal epithelium, being able to establish an early biofilm structure to which other
BV-associated species can attach (Muzny et al., 2019). However, the role of these species in
the development and progress of BV is still poorly understood and therefore, more studies
are needed to unravel this matter.
We showed before that BV-associated species had different abilities to grow as biofilms,
and this was strongly dependent on the growth media (Alves et al., 2014). As such, the
first step in facilitating BV multi-species biofilm studies is to determine optimal culture
medium conditions suitable for multiple BV-associates species, considering to further
investigate the interactions that might exist between them in BVmulti-species biofilms and
their implications in BV process.
Although sBHI has been widely used as a medium that supports Gardnerella spp.
growth (Algburi, Volski & Chikindas, 2015; Gottschick et al., 2016; Harwich et al., 2010;
Machado, Palmeira-de-Oliveira & Cerca, 2015; Patterson et al., 2010; Turovskiy et al., 2012;
Weeks et al., 2019), it did not facilitate the planktonic growth or biofilm formation for
some of the tested species, including A. vaginae, L. iners and M. curtisii. The same was
observed for these three species in SB medium, even though the manufacturer describes it
as a medium suitable for the cultivation of anaerobic microorganisms, providing them
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an important amount of amino acids, nitrogen, vitamins as well as the energy necessary for
growth. In an early study, after evaluating nine broth media in varied CO2 atmospheres for
their ability to support the growth of anaerobic bacteria including Bacteroides fragilis
subspecies fragilis, Peptostreptococcus CDC group 2, Eubacterium alactolyticum and
Clostridium perfringens, Stalons, Thornsberry & Dowell (1974) found that SB in an
Figure 2 Biofilm formation of BV-associated bacteria in the nine different culture media over a 72 h
period. Biofilm biomass was quantified using the crystal violet staining assay. (A) The total biofilm
biomass formed by Gardnerella sp. in the tested culture media. (B) The total biofilm biomass formed by
A. vaginae. (C) The total biofilm biomass formed by L. iners. (D) The total biofilm biomass formed by
M. curtisii. (E) The total biofilm biomass formed by P. anaerobius. (F) The total biofilm biomass formed
by P. bivia. Results are expressed as the average ± standard deviation of at least three independent
experiments performed with eight technical replicates. Statistical analysis was performed using one-way
ANOVA and Dunnett’s multiple comparisons test. Significant differences between biofilm biomass
formed in NYC medium (our culture medium of choice) and other culture media are represented with
p < 0.05 and p < 0.01. Other statistical analysis is shown in Table S2.
Full-size DOI: 10.7717/peerj.9917/fig-2
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atmosphere of 5% CO2, 10% hydrogen and 85% nitrogen exhibited the fastest and highest
growth response. However, in our in vitro conditions, we obtained high levels of
planktonic growth only for P. anaerobius, probably because this medium is not
appropriate for the growth of all species of anaerobic microorganisms. Still, SB was a good
medium to support in vitro biofilm formation with high levels of the biomass for
Gardnerella sp., P. anaerobius and P. bivia. Interestingly, Gardnerella sp. and P. bivia
showed in SB the lowest levels of planktonic growth, but the highest biofilm formation
ability. As mentioned, SB is a complex medium and perhaps the presence of certain growth
factors determined these two anaerobes to turn on the expression of biofilm-related genes.
Another of the tested media, BHV, also described by the manufacturer as suitable for
the cultivation of anaerobes, was not appropriate for the growth and biofilm formation of
the tested species, with the exception of planktonic growth by P. anaerobius (Fig. 1).
Interestingly, NYC facilitated the planktonic growth of all tested species, despite
M. curtisii presented a very slow growth rate. Nevertheless, even M. curtisii was able to
form high biofilm biomass in this medium. In fact, together with A. vaginae and L. iners,
significant biofilm formation was only detected in NYC (Fig. 2). A particularity of
NYCmedium, compared to the other tested media, is the presence of proteose peptone no.
3, which has been described by the manufacturer as offering high nutritional benefits
to fastidious anaerobic species by providing the necessary amount of nitrogen, carbon,
amino acids and essential growth factors. To assess if, in fact, the enhancement of biofilm
formation in NYC was mainly due to the presence of proteose peptone no. 3, we carried
out an experiment by evaluating the biofilm-formation ability of the six tested bacterial
species in the original recipe of NYC versus an altered version of NYC [with regular
peptone from meat (Acros Organics, UK) replacing the proteose peptone no. 3].
Interestingly, while we did find that proteose peptone no. 3 was essential to the biofilm
formation by M. curtisii, no significant differences were found for the other species
(Fig. S1), which suggests that NYCʼs ability to enhance biofilm formation is not only
related to the presence of proteose peptone no. 3.
Besides the commercially available media, we also tested a chemically defined medium
that simulates the genital tract fluid, mGTS (Stingley et al., 2014). Since mGTS is a minimal
medium without rich nutrient sources, it was not surprising that the growth of the
tested BV-associated species was negligent or very slow in this medium. Nevertheless,
biofilm formation by Gardnerella sp. and P. anaerobius was significant under mGTS,
further being confirmed that biofilm formation requires specific conditions, different from
planktonic growth.
We also tested another variable in our growth conditions optimization. The addition
of L-ascorbic acid had the advantage of reducing the oxidation potential of the growth
media by removing the oxygen (La Scola et al., 2014). However, the effect of adding
L-ascorbic acid was very variable, depending not only on the bacterial species but also on the
respective growth media. Nevertheless, there was a tendency to slightly or highly suppress
biofilm formation. Interestingly, the inhibition of biofilm formation by ascorbic acid has
been described before in biofilms of Bacillus subtilis, Escherichia coli, Pseudomonas
aeruginosa (Pandit et al., 2017) as well as of methicillin-resistant Staphylococcus aureus
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(Mirani et al., 2018). It should be noted that at higher concentrations, L-ascorbic acid
has been reported as a possible adjuvant for antibiotic treatment of BV, playing a
role in maintaining a low vaginal pH, which favors the recolonization of the vaginal
environment with lactic acid-producing bacteria, decreasing, thereby, the risk of BV
recurrence (Krasnopolsky et al., 2013; Polatti et al., 2006). Our data further expand these
previous findings by demonstrating that, while sometimes favoring planktonic growth,
L-ascorbic acid often impairs biofilm formation.
A limitation of this study was the fact that we only tested a yet unidentified Gardnerella
sp. isolate, but at least three new species have been recently reported. Previously, we
assessed biofilm formation by seven clinical isolates from BV-women and seven from
healthy microbiota and found no significant differences between the ability to form
biofilms by the 2 groups, using different growth media (Castro et al., 2015). We now know
that from those 14 isolates, some belong to G. vaginalis, G. leopoldii, G. piotii and
G. swidsinskii (Castro et al., 2020). As such, we hypothesized that the four Gardnerella
species would have similar biofilm formation abilities in our growth medium of choice:
NYC. To test this hypothesis, we selected one isolate of each species, previously found to
form similar biofilms in sBHI (Castro et al., 2020; Vaneechoutte et al., 2019), and compared
its biofilms with NYC medium. As shown in Fig. S2, all the tested species had a similar
biofilm-formation ability as compared to Gardnerella sp. UM241, with G. leopoldii
showing a slight decrease in biomass, but well within the expected variation found in
different Gardnerella strains (Castro et al., 2015).
CONCLUSIONS
Overall, our work has shed new light on the optimal conditions required for in vitro
growth and biofilm formation of bacteria associated with BV. Although we tested nine
different growth conditions, including a medium simulating genital tract secretions
(mGTS), none of them is able to account for all growth factors present in the vaginal
environment, including components of the host immune system, that are known to
interfere in bacterial growth (Castro, Jefferson & Cerca, 2018). Nevertheless, this work
highlighted that under the appropriate in vitro conditions, some of the most common
species found in BV can form single-species biofilms, contrary to what was shown before
(Castro et al., 2020; Patterson et al., 2010). NYC medium revealed to be an ideal candidate
for future studies addressing multi-species biofilm formation since this growth medium
allowed significant levels of single-species biofilm formation. Understanding microbial
interactions that occur during BV development is crucial for the development of novel
antimicrobial strategies, and future work will help to clarify some of these crucial
interactions in multi-species biofilms.
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